$MDGL

$475.00▲ +10.2% YTD

5 SEC 13D/G filings tracked · Last updated Nov 3, 2026

Filing History

News

MDGL ▲ +10.2% - Madrigal Pharmaceuticals, Inc.

CP $475.00▲ +10.2%Nov 3, 2026 · ThinkSabio Blog

$MDGL - Madrigal Pharmaceuticals Reports Third-Quarter 2026 Financial Results and Provides Corporate Updates…

News

MDGL ▼ -0.2% - Madrigal Pharmaceuticals, Inc.

CP $437.74▲ -0.2%Oct 27, 2026 · ThinkSabio Blog

$MDGL - Madrigal to Present Multiple Abstracts at AASLD's The Liver Meeting 2026, Including New Real-World Evidence Reinforcing Rezdiffra as a Foundat…

News

MDGL ▼ -0.0% - Madrigal Pharmaceuticals, Inc.

CP $447.09▲ -0.0%Oct 20, 2026 · ThinkSabio Blog

$MDGL - Madrigal Pharmaceuticals to Release Third-Quarter 2026 Financial Results and Host Webcast on November 3, 2026…

News

MDGL ▲ +1.0% - Madrigal Pharmaceuticals, Inc.

CP $529.09▲ +1.0%Sep 16, 2026 · ThinkSabio Blog

$MDGL - Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)…

SEC 13D/G

$MDGL SEC Filing Update (29-JUL-2026) | ThinkSabio - Stocks Simplified

$547.37▼ -7.70%Jul 29, 2026 · ThinkSabio Blog

$MDGL SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #MDGL : $547.37 Sector: Healthcare | YTD: 🔽 -7.70% The SEC discl…